A Mitochondria‐Targeted Nanozyme Platform for Multi‐Pathway Tumor Therapy via Ferroptosis and Cuproptosis Regulation (Adv. Sci. 36/2025)
Advanced Science · 2025-09 · 12 (36)
DOI: 10.1002/advs.71745 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 25.09.2025. Verfasst von Chenguang Liu und 8 weiteren Autor:innen. Die Arbeit wurde bisher 20-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Liu, C., Guo, L., Cheng, Y., Gao, J., Pan, H., Zhu, J., Li, D., Jiao, L., & Fu, C. (2025). A Mitochondria‐Targeted Nanozyme Platform for Multi‐Pathway Tumor Therapy via Ferroptosis and Cuproptosis Regulation (Adv. Sci. 36/2025). Advanced Science, 12(36). https://doi.org/10.1002/advs.71745
Vancouver
Liu C, Guo L, Cheng Y, Gao J, Pan H, Zhu J, et al. A Mitochondria‐Targeted Nanozyme Platform for Multi‐Pathway Tumor Therapy via Ferroptosis and Cuproptosis Regulation (Adv. Sci. 36/2025). Advanced Science. 2025;12(36). doi:10.1002/advs.71745
BibTeX
@article{Liu2025,
author = {Liu, Chenguang and Guo, Lingxiao and Cheng, Yuying and Gao, Jingjie and Pan, Hanling and Zhu, Jiayi and Li, Danting and Jiao, Liqing and Fu, Caiyun},
title = {A Mitochondria‐Targeted Nanozyme Platform for Multi‐Pathway Tumor Therapy via Ferroptosis and Cuproptosis Regulation (Adv. Sci. 36/2025)},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {36},
doi = {10.1002/advs.71745}
}
EUVIMED